Cited by 2,012Ferroptosis and cancer prognosisGenomics, phytochemicals, and oxidative stressIron Metabolism and Disorders

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Activation of the p62–Keap1–NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells

Open access

Sun, Xiaofang, Ou, Zhanhui, Chen, Ruochan, Niu, Xiaohua, Chen, De, Kang, Rui, Tang, Daolin·2016·Hepatology

DOI 10.1002/hep.28251PMC PMC4688087

Open this paper in CoChat — free account Open PDF

Abstract

Ferroptosis is a recently recognized form of regulated cell death caused by an iron‐dependent accumulation of lipid reactive oxygen species. However, the molecular mechanisms regulating ferroptosis remain obscure. Here, we report that nuclear factor erythroid 2‐related factor 2 (NRF2) plays a central role in protecting hepatocellular carcinoma (HCC) cells against ferroptosis. Upon exposure to ferroptosis‐inducing compounds (e.g., erastin, sorafenib, and buthionine sulfoximine), p62 expression prevented NRF2 degradation and enhanced subsequent NRF2 nuclear accumulation through inactivation of Kelch‐like ECH‐associated protein 1. Additionally, nuclear NRF2 interacted with transcriptional coactivator small v‐maf avian musculoaponeurotic fibrosarcoma oncogene homolog proteins such as MafG and then activated transcription of quinone oxidoreductase‐1, heme oxygenase‐1, and ferritin heavy chain‐1. Knockdown of p62, quinone oxidoreductase‐1, heme oxygenase‐1, and ferritin heavy chain‐1 by RNA interference in HCC cells promoted ferroptosis in response to erastin and sorafenib. Furthermore, genetic or pharmacologic inhibition of NRF2 expression/activity in HCC cells increased the anticancer activity of erastin and sorafenib in vitro and in tumor xenograft models. Conclusion: These findings demonstrate novel molecular mechanisms and signaling pathways of ferroptosis; the status of NRF2 is a key factor that determines the therapeutic response to ferroptosis‐targeted therapies in HCC cells. (H epatology 2016;63:173–184)

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/hep.28251

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Global cancer statistics
Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,044
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
Kudo, M. (2017) · Liver Cancer · doi:10.1159/000462153 · Cited by 5,974
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Role of nrf2 in oxidative stress and toxicity
Ma, Q. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140320 · Cited by 4,903
An Nrf2/Small Maf Heterodimer Mediates the Induction of Phase II Detoxifying Enzyme Genes through Antioxidant Response Elements
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
Friedmann Angeli, J. P., Schneider, M., Proneth, B., Tyurina, Y. Y., Tyurin, V. A., Hammond, V. J., Herbach, N., Aichler, M., Walch, A., Eggenhofer, E., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3064 · Cited by 3,732
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398

Flagged first, then by citations

Show all 40 references

Sorted by citations

Items 301–400 of 1,001

Targeting Molecular Mediators of Ferroptosis and Oxidative Stress for Neurological Disorders
Li, J., Jia, B., Cheng, Y., Song, Y., Li, Q., & Luo, C. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3999083 · Cited by 136
Ferroptosis contributes to hypoxic–ischemic brain injury in neonatal rats: Role of the SIRT1 /Nrf2/ GPx4 signaling pathway
Li, C., Wu, Z., Xue, H., Gao, Q., Zhang, Y., Wang, C., & Zhao, P. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13973 · Cited by 132
Saponin Formosanin C-Induced Ferritinophagy and Ferroptosis in Human Hepatocellular Carcinoma Cells
Lin, P.-L., Tang, H. F., Wu, S., Shaw, N.-S., & Su, C. (2020) · Antioxidants · doi:10.3390/antiox9080682 · Cited by 129
Non-apoptotic cell death-based cancer therapy: Molecular mechanism, pharmacological modulators, and nanomedicine
Wang, X., Hua, P., He, C., & Chen, M. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.03.020 · Cited by 131
The Interplay between Intracellular Iron Homeostasis and Neuroinflammation in Neurodegenerative Diseases
Lee, J., & Hyun, D. (2023) · Antioxidants · doi:10.3390/antiox12040918 · Cited by 142
Novel insights on targeting ferroptosis in cancer therapy
Zuo, S., Yu, J., Pan, H., & Lu, L. (2020) · Biomarker Research · doi:10.1186/s40364-020-00229-w · Cited by 128
Novel insights into ferroptosis: Implications for age-related diseases
Zhou, R., Chen, Y., Wei, X., Yu, B., Xiong, Z., Lu, C., & Hu, W. M. (2020) · Theranostics · doi:10.7150/thno.50663 · Cited by 134
Regulating Nrf2-GPx4 axis by bicyclol can prevent ferroptosis in carbon tetrachloride-induced acute liver injury in mice
Zhao, T., Yu, Z., Zhou, L., Wang, X., Hui, Y., Mao, L., Fan, X., Wang, B., Zhao, X., & Sun, C. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01173-4 · Cited by 128
Context-dependent regulation of ferroptosis sensitivity
Magtanong, L., Mueller, G. D., Williams, K. J., Billmann, M., Chan, K., Armenta, D. A., Pope, L. E., Moffat, J., Boone, C. M., Myers, C. L., et al. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2022.06.004 · Cited by 136
Ferroptosis in immunostimulation and immunosuppression
Tang, D., Kroemer, G., & Kang, R. (2023) · Immunological Reviews · doi:10.1111/imr.13235 · Cited by 129
Self-citation
Mechanisms and regulations of ferroptosis
Zhang, X.-D., Liu, Z., Wang, M.-S., Guo, Y.-X., Wang, X., Luo, K., Huang, S., & Li, R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1269451 · Cited by 138
Ferroptotic therapy in cancer: benefits, side effects, and risks
Diao, J., Jia, Y., Dai, E., Liu, J., Kang, R., Tang, D., Han, L., Zhong, Y., & Meng, L. (2024) · Molecular Cancer · doi:10.1186/s12943-024-01999-9 · Cited by 135
Self-citation
Recent progress on targeting ferroptosis for cancer therapy
Xu, G., Wang, H., Li, X., Huang, R., & Luo, L. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114584 · Cited by 121
Regulatory pathways and drugs associated with ferroptosis in tumors
Wang, D., Tang, L. M., Zhang, Y., Ge, G., Jiang, X., Mo, Y., Wu, P., Deng, X., Li, L., Zuo, S., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04927-1 · Cited by 131
Butyrate ameliorated ferroptosis in ulcerative colitis through modulating Nrf2/GPX4 signal pathway and improving intestinal barrier
Chen, H., Qian, Y., Jiang, C., Tang, L., Yu, J., Zhang, L., Dai, Y., & Jiang, G. Z. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166984 · Cited by 136
Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma
Liu, Y., Zhang, X., Zhang, J., Tan, J., Li, J., & Song, Z. (2020) · Frontiers in Cell and Developmental Biology · doi:10.2139/ssrn.3678770 · Cited by 126
Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1/Nrf2-ARE signaling pathway to reduce ferroptosis
Gao, G., Xie, Z., Li, E.-W., Yuan, Y., Fu, Y., Wang, P., Zhang, X., Qiao, Y., Xu, J., Hölscher, C., et al. (2021) · Journal of Natural Medicines · doi:10.1007/s11418-021-01491-4 · Cited by 124
Combination of autophagy and NFE2L2/NRF2 activation as a treatment approach for neuropathic pain
Li, J., Tian, M., Hua, T., Wang, H., Yang, M., Li, W., Zhang, X., & Yuan, H. (2021) · Autophagy · doi:10.1080/15548627.2021.1900498 · Cited by 123
Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer
Cheu, J. W., Lee, D. P. H., Li, Q., Goh, C. C., Bao, M. H., Yuen, V. W., Zhang, M. S., Yang, C., Chan, C. Y., Tse, A. P., et al. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.03.001 · Cited by 126
Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis
Hendricks, J. M., Doubravsky, C. E., Wehri, E., Li, Z., Roberts, M. A., Deol, K. K., Lange, M., Lasheras-Otero, I., Momper, J. D., Dixon, S. J., et al. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.04.007 · Cited by 129
CREB stimulates GPX4 transcription to inhibit ferroptosis in lung adenocarcinoma
Wang, Z., Zhang, X., Tian, X., Yang, Y., Ma, L., Wang, J., & Yu, Y. (2021) · Oncology Reports · doi:10.3892/or.2021.8039 · Cited by 122
Roles of Nrf2 in Liver Diseases: Molecular, Pharmacological, and Epigenetic Aspects
Galicia‐Moreno, M., Lucano‐Landeros, S., Monroy-Ramírez, H. C., Silva-Gómez, J. A., Gutiérrez‐Cuevas, J., Santos, A., & Armendáriz‐Borunda, J. (2020) · Antioxidants · doi:10.3390/antiox9100980 · Cited by 124
Modulation of Nrf2 and NF-κB Signaling Pathways by Naturally Occurring Compounds in Relation to Cancer Prevention and Therapy. Are Combinations Better Than Single Compounds?
Krajka‐Kuźniak, V., & Baer‐Dubowska, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158223 · Cited by 123
FTO Prevents Thyroid Cancer Progression by SLC7A11 m6A Methylation in a Ferroptosis-Dependent Manner
Ji, F., Fu, X.-H., Li, G., He, Q., & Qiu, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.857765 · Cited by 125
Mechanism of glycyrrhizin on ferroptosis during acute liver failure by inhibiting oxidative stress
Wang, Y., Chen, Q., Shi, C., Jiao, F., & Gong, Z. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10660 · Cited by 119
Iron Metabolism and Ferroptosis in Epilepsy
Chen, S., Chen, Y., Zhang, Y., Kuang, X., Liu, Y., Guo, M., Ma, L., Zhang, D., & Li, Q. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.601193 · Cited by 122
Inhibition of CISD2 promotes ferroptosis through ferritinophagy-mediated ferritin turnover and regulation of p62–Keap1–NRF2 pathway
Li, Y., Xu, B., Ren, X., Wang, L., Xu, Y., Zhao, Y., Yang, C., Chen, Y., Li, Y., Tong, X., et al. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00383-z · Cited by 121
Iron and magnetic: new research direction of the ferroptosis-based cancer therapy.
Wang, S., Luo, J., Zhang, Z., Dong, D., Shen, Y., Fang, Y., Hu, L., Liu, M., Dai, C., Peng, S., et al. (2018) · Europe PMC (PubMed Central) · Cited by 117
Ferroptosis and Acute Kidney Injury (AKI): Molecular Mechanisms and Therapeutic Potentials
Feng, Q., Yu, X., Qiao, Y., Pan, S., Wang, R., Zheng, B., Wang, H., Ren, K., Liu, H., & Yang, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.858676 · Cited by 118
Astragaloside IV mitigates cerebral ischaemia-reperfusion injury via inhibition of P62/Keap1/Nrf2 pathway-mediated ferroptosis
Wang, L., Liu, C., Wang, L., & Tang, B. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175516 · Cited by 118
Ferroptosis: An emerging therapeutic opportunity for cancer
Wang, L., Chen, X., & Yan, C. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.09.005 · Cited by 120
High Level of Uric Acid Promotes Atherosclerosis by Targeting NRF2‐Mediated Autophagy Dysfunction and Ferroptosis
Yu, W., Liu, W., Xie, D., Wang, Q., Xu, C., Zhao, H., Lv, J., He, F., Chen, B., Yamamoto, T., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/9304383 · Cited by 117
Anti-Ferroptotic Effects of Nrf2: Beyond the Antioxidant Response
Shakya, A., McKee, N. W., Dodson, M. B., Chapman, E., & Zhang, D. D. (2023) · Molecules and Cells · doi:10.14348/molcells.2023.0005 · Cited by 120
(+)-Clausenamide protects against drug-induced liver injury by inhibiting hepatocyte ferroptosis
Wang, M., Liu, C., Wang, T., Yu, H.-M., Ouyang, S., Wu, Y., Gong, H., Ma, X., Jiao, G., Fu, L., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02961-5 · Cited by 116
Cathepsin B is a mediator of organelle-specific initiation of ferroptosis
Kuang, F., Liu, J., Li, C., Kang, R., & Tang, D. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.10.035 · Cited by 115
Self-citation
Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor‐4 inhibition in hepatocellular carcinoma
Iseda, N., Itoh, S., Toshida, K., Tomiyama, T., Morinaga, A., Shimokawa, M., Shimagaki, T., Wang, H., Kurihara, T., Toshima, T., et al. (2022) · Cancer Science · doi:10.1111/cas.15378 · Cited by 117
Ferroptosis in mitochondrial cardiomyopathy
Ahola, S., & Langer, T. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.06.002 · Cited by 118
Ferroptosis: a novel regulated cell death participating in cellular stress response, radiotherapy, and immunotherapy
Zheng, X., Jin, X., Ye, F., Liu, X., Yu, B., Li, Z., Zhao, T., Chen, W., Liu, X., Di, C., et al. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00427-w · Cited by 125
Reclassifying Hepatic Cell Death during Liver Damage: Ferroptosis—A Novel Form of Non-Apoptotic Cell Death?
Macías‐Rodríguez, R. U., Inzaugarat, M. E., Ruiz‐Margáin, A., Nelson, L. J., Trautwein, C., & Cubero, F. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051651 · Cited by 116
Ferroptosis in heart failure
Yang, X., Kawasaki, N. K., Min, J., Matsui, T., & Wang, F. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.10.004 · Cited by 117
In situ hydrogel based on Cu–Fe3O4 nanoclusters exploits oxidative stress and the ferroptosis/cuproptosis pathway for chemodynamic therapy
Zhang, Y., Zhang, N., Xing, J., Sun, Y., Xu, J., Shen, C., Cheng, L., Wang, Y., & Wang, X. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122675 · Cited by 120
The Potential Role of Ferroptosis in Neonatal Brain Injury
Wu, Y., Song, J., Wang, Y., Wang, X., Culmsee, C., & Zhu, C. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00115 · Cited by 116
The Molecular Mechanisms of Regulating Oxidative Stress-Induced Ferroptosis and Therapeutic Strategy in Tumors
Zhu, J., Xiong, Y., Zhang, Y., Wen, J., Cai, N., Cheng, K., Liang, H., & Zhang, W. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8810785 · Cited by 116
Emerging role of ferroptosis in breast cancer: New dawn for overcoming tumor progression
Sui, S., Xu, S., & Pang, D. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107992 · Cited by 117
Ferroptosis‐modulating small molecules for targeting drug‐resistant cancer: Challenges and opportunities in manipulating redox signaling
Koeberle, S. C., Kipp, A. P., Stuppner, H., & Koeberle, A. (2023) · Medicinal Research Reviews · doi:10.1002/med.21933 · Cited by 117
p62/ SQSTM 1—Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer
Taniguchi, K., Yamachika, S., He, F., & Karin, M. (2016) · FEBS Letters · doi:10.1002/1873-3468.12301 · Cited by 117
A novel PINK1- and PARK2-dependent protective neuroimmune pathway in lethal sepsis
Kang, R., Zeng, L., Xie, Y., Yan, Z., Zhou, B., Cao, L., Klionsky, D. J., Tracey, K. J., Li, J., Wang, H., et al. (2016) · Autophagy · doi:10.1080/15548627.2016.1239678 · Cited by 110
Self-citation
Fumarate hydratase inactivation in hereditary leiomyomatosis and renal cell cancer is synthetic lethal with ferroptosis induction
Kerins, M. J., Milligan, J., Wohlschlegel, J. A., & Ooi, A. (2018) · Cancer Science · doi:10.1111/cas.13701 · Cited by 111
A Potential Mechanism of Temozolomide Resistance in Glioma–Ferroptosis
Hu, Z., Mi, Y., Qian, H., Guo, N., Yan, A., Zhang, Y., & Gao, X. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00897 · Cited by 112
The Multifaceted Regulation of Mitochondria in Ferroptosis
Wu, H., Wang, F., Ta, N., Zhang, T., & Gao, W. (2021) · Life · doi:10.3390/life11030222 · Cited by 111
Ferroptosis in colorectal cancer: a future target?
Yan, H. Y., Talty, R., Aladelokun, O. B., Bosenberg, M., & Johnson, C. H. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02149-6 · Cited by 115
Advanced glycation end products and reactive oxygen species: uncovering the potential role of ferroptosis in diabetic complications
Chen, Y., Meng, Z., Li, Y., Liu, S., Hu, P. L., & Luo, E. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00905-9 · Cited by 132
Redox biology of regulated cell death in cancer: A focus on necroptosis and ferroptosis
Florean, C., Song, S., Dicato, M. A., & Diederich, M. F. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.01.008 · Cited by 110
Ferrostatin-1 protects HT-22 cells from oxidative toxicity
Li, Q., Chu, J., Liu, C.-X., & Song, R. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.266060 · Cited by 108
Luteolin Exerts Neuroprotection via Modulation of the p62/Keap1/Nrf2 Pathway in Intracerebral Hemorrhage
Tan, X. L., Yang, Y., Xu, J., Zhang, P., Deng, R., Mao, Y.-G., He, J., Chen, Y., Zhang, Y., Ding, J., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01551 · Cited by 110
Ferroptosis and its potential as a therapeutic target
Yuan, H., Pratte, J., & Giardina, C. A. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114486 · Cited by 113
Macropinocytosis is an alternative pathway of cysteine acquisition and mitigates sorafenib-induced ferroptosis in hepatocellular carcinoma
Byun, J., Lee, S., Kang, G. W., Lee, Y. R., Park, S. Y., Song, I., Yun, J. W., Lee, J., Choi, Y., & Park, K. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02296-3 · Cited by 112
Regulation of ferroptosis in cancer cells by YAP/TAZ and Hippo pathways: The therapeutic implications
Sun, T., & Chi, J. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.05.004 · Cited by 111
Transferrin receptor-mediated reactive oxygen species promotes ferroptosis of KGN cells via regulating NADPH oxidase 1/PTEN induced kinase 1/acyl-CoA synthetase long chain family member 4 signaling
Zhang, L., Wang, F., Li, D., Yan, Y.-F., & Wang, H. (2021) · Bioengineered · doi:10.1080/21655979.2021.1956403 · Cited by 110
Metabolic networks in ferroptosis (Review)
Hao, S., Liang, B., Huang, Q., Dong, S., Wu, Z., He, W., & Shi, M. (2018) · Oncology Letters · doi:10.3892/ol.2018.8066 · Cited by 109
Oleanolic acid inhibits cervical cancer Hela cell proliferation through modulation of the ACSL4 ferroptosis signaling pathway
Xiaofei, J., Shi, M., Miao, S., Yizhen, Y., Zhang, S., Xia, Q., & Kai, Z. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.01.028 · Cited by 108
The Cross‐Link between Ferroptosis and Kidney Diseases
Wang, J., Liu, Y., Wang, Y., & Sun, L. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6654887 · Cited by 108
Molecular mechanisms of ROS-modulated cancer chemoresistance and therapeutic strategies
Zhou, X., An, B., Lin, Y., Ni, Y., Zhao, X., & Liang, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115036 · Cited by 112
Ferroptosis: A Trigger of Proinflammatory State Progression to Immunogenicity in Necroinflammatory Disease
Li, J., Yao, Y.-M., & Tian, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.701163 · Cited by 111
Metabolic regulation of ferroptosis in the tumor microenvironment
Mbah, N. E., & Lyssiotis, C. A. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101617 · Cited by 113
Targeting a novel inducible GPX4 alternative isoform to alleviate ferroptosis and treat metabolic-associated fatty liver disease
Tong, J., Li, D., Meng, H., Sun, D.-Y., Lan, X.-T., Ni, M., Ma, J., Zeng, F., Sun, S., Fu, J., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.02.003 · Cited by 111
The role of ferroptosis mediated by NRF2/ERK-regulated ferritinophagy in CdTe QDs-induced inflammation in macrophage
Liu, N., Liang, Y., Wei, T., Zou, L., Huang, X., Kong, L., Tang, M., & Zhang, T. (2022) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2022.129043 · Cited by 106
An overview of ferroptosis in non-alcoholic fatty liver disease
Wang, S., Liu, Z., Geng, J., Li, L., & Feng, X. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113374 · Cited by 107
ATF4 in cellular stress, ferroptosis, and cancer
Tang, H., Kang, R., Liu, J., & Tang, D. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03681-x · Cited by 117
Self-citation
Dual Role of ROS as Signal and Stress Agents: Iron Tips the Balance in favor of Toxic Effects
Gammella, E., Recalcati, S., & Cairo, G. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8629024 · Cited by 108
Umbelliferone delays the progression of diabetic nephropathy by inhibiting ferroptosis through activation of the Nrf-2/HO-1 pathway
Jin, T., & Chen, C. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.112892 · Cited by 102
Ferroptosis regulation by the NGLY1/NFE2L1 pathway
Forcina, G. C., Pope, L. E., Murray, M. B., Dong, W., Abu-Remaileh, M., Bertozzi, C. R., & Dixon, S. J. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2118646119 · Cited by 103
Itaconate transporter SLC13A3 impairs tumor immunity via endowing ferroptosis resistance
Lin, H., Tison, K., Du, Y., Kirchhoff, P. D., Kim, C., Wang, W., Yang, H., Pitter, M. R., Yu, J., Liao, P., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.10.010 · Cited by 111
Non-apoptotic cell death in malignant tumor cells and natural compounds
Ye, J., Zhang, R., Wu, F., Zhai, L., Wang, K., Xiao, M., Xie, T., & Sui, X. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.061 · Cited by 103
The Mechanism of Ferroptosis and Applications in Tumor Treatment
Lin, X., Ping, J., Wen, Y., & Wu, Y. R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01061 · Cited by 107
Nutritional and Metabolic Control of Ferroptosis
Mishima, E., & Conrad, M. (2022) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-062320-114541 · Cited by 107
Mechanisms of Ferroptosis and Emerging Links to the Pathology of Neurodegenerative Diseases
Sun, Y., Xia, X., Basnet, D., Zheng, J., Huang, J., & Liu, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.904152 · Cited by 105
Loss of LncRNA DUXAP8 synergistically enhanced sorafenib induced ferroptosis in hepatocellular carcinoma via SLC7A11 de‐palmitoylation
Shi, Z., Li, Z., Jin, B., Ye, W., Wang, L., Zhang, S., Zheng, J., Lin, Z., Chen, B., Liu, F., et al. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1300 · Cited by 104
Role of Ferroptosis in Non-Alcoholic Fatty Liver Disease and Its Implications for Therapeutic Strategies
Zhang, H., Zhang, E., & Hu, H. (2021) · Biomedicines · doi:10.3390/biomedicines9111660 · Cited by 104
miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathways
Bi, G., Liang, J., Zhao, M., Zhang, H., Jin, X. Y., Lu, T., Zheng, Y., Bian, Y., Chen, Z., Huang, Y., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.03.020 · Cited by 105
Ferroptosis as a Novel Therapeutic Target for Diabetes and Its Complications
Yang, X., & Yang, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.853822 · Cited by 110
Glycosylation of KEAP1 links nutrient sensing to redox stress signaling
Chen, P., Smith, T. J., Wu, J., Siesser, P. F., Bisnett, B. J., Khan, F., Hogue, M., Soderblom, E. J., Tang, F., Marks, J. R., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201696113 · Cited by 105
Ferroptosis: A Novel Mechanism of Artemisinin and its Derivatives in Cancer Therapy
Zhu, S., Yu, Q., Huo, C., Li, Y., He, L., Ran, B., Chen, J., Li, Y., & Liu, W. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200121124404 · Cited by 104
Understanding sorafenib-induced ferroptosis and resistance mechanisms: Implications for cancer therapy
Li, Q., Chen, K., Zhang, T., Jiang, D., Chen, L., Jiang, J., Zhang, C., & Li, S. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175913 · Cited by 106
Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases
Xiang, Y., Song, X., & Long, D. (2024) · Archives of Toxicology · doi:10.1007/s00204-023-03660-8 · Cited by 116
Emerging mechanisms and applications of ferroptosis in the treatment of resistant cancers
Li, B., Yang, L., Peng, X., Fan, Q., Wei, S., Yang, S., Li, X., Jin, H., Wu, B., Huang, M., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110710 · Cited by 104
Ferroptosis in Different Pathological Contexts Seen through the Eyes of Mitochondria
Otašević, V., Vučetić, M., Grigorov, I., Martinović, V., & Stančić, A. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5537330 · Cited by 104
Autophagy-Dependent Ferroptosis in Cancer
Chen, F., Cai, X., Kang, R., Liu, J., & Tang, D. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0202 · Cited by 104
Self-citation
RNA binding protein DAZAP1 promotes HCC progression and regulates ferroptosis by interacting with SLC7A11 mRNA
Wang, Q., Guo, Y., Wang, W., Liu, B., Yang, G., Xu, Z., Li, J., & Liu, Z. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112453 · Cited by 100
The lipoprotein-associated phospholipase A2 inhibitor Darapladib sensitises cancer cells to ferroptosis by remodelling lipid metabolism
Oh, M., Jang, S. Y., Lee, J.-Y., Kim, J. W., Jung, Y., Kim, J., Seo, J., Han, T., Jang, E., Son, H. Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41462-9 · Cited by 112
Newcastle Disease Virus Induced Ferroptosis Through p53-SLC7A11-GPX4 Axis Mediated Nutrient Deprivation in Tumor Cells
Kan, X., Yin, Y., Song, C., Tan, L., Qiu, X., Liao, Y., Liu, W., Meng, S., Sun, Y., & Ding, C. (2021) · iScience · doi:10.1016/j.isci.2021.102837 · Cited by 101
Activation of KEAP1/NRF2/P62 signaling alleviates high phosphate-induced calcification of vascular smooth muscle cells by suppressing reactive oxygen species production
Wei, R., Enaka, M., & Muragaki, Y. (2019) · Scientific Reports · doi:10.1038/s41598-019-46824-2 · Cited by 100
The deubiquitinase USP11 regulates cell proliferation and ferroptotic cell death via stabilization of NRF2 USP11 deubiquitinates and stabilizes NRF2
Meng, C., Zhan, J., Chen, D., Shao, G., Zhang, H., Gu, W. J., & Luo, J. (2021) · Oncogene · doi:10.1038/s41388-021-01660-5 · Cited by 99
Self-citation
Caveolin-1 dictates ferroptosis in the execution of acute immune-mediated hepatic damage by attenuating nitrogen stress
Deng, G., Li, Y., Ma, S., Gao, Z., Zeng, T., Chen, L., Ye, H., Yang, M., Shi, H., Yao, X., et al. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.12.026 · Cited by 98
The NRF2/KEAP1 Axis in the Regulation of Tumor Metabolism: Mechanisms and Therapeutic Perspectives
Panieri, E., Telkoparan‐Akillilar, P., Süzen, S., & Saso, L. (2020) · Biomolecules · doi:10.3390/biom10050791 · Cited by 102
Ferroptosis and Its Role in Epilepsy
Cai, Y., & Yang, Z. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.696889 · Cited by 97
Melatonin suppresses ferroptosis via activation of the Nrf2/HO-1 signaling pathway in the mouse model of sepsis-induced acute kidney injury
Qiu, W., An, S. L., Wang, T., Li, J., Yu, B., Zeng, Z., Chen, Z., Lin, B., Lin, X., & Gao, Y. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109162 · Cited by 99
Nrf2 Modulation in Breast Cancer
Ghareghomi, S., Habibi-Rezaei, M., Arese, M., Saso, L., & Moosavi‐Movahedi, A. A. (2022) · Biomedicines · doi:10.3390/biomedicines10102668 · Cited by 97
Toward improved human health: Nrf2 plays a critical role in regulating ferroptosis
Lu, J., Zhao, Y., Liu, M., Lu, J., & Guan, S. (2021) · Food & Function · doi:10.1039/d1fo01036k · Cited by 97
Cadmium attenuates testosterone synthesis by promoting ferroptosis and blocking autophagosome-lysosome fusion
Zeng, L., Zhou, J., Wang, X., Zhang, Y., Wang, M., & Su, P. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.09.028 · Cited by 96

Authors: Sun, X., Ou, Z., Chen, R., Niu, X., Chen, D., Kang, R., & Tang, D.
Affiliations: Third Affiliated Hospital of Guangzhou Medical University (CN)
University of Pittsburgh (US)
Corresponding author: Tang, Daolin
ORCID: Sun, Xiaofang
Ou, Zhanhui
Chen, Ruochan
Niu, Xiaohua
Chen, De
Kang, Rui
Tang, Daolin
Venue: Hepatology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2015-11-26
Volume: 63
Issue: 1
Pages: 173-184
ISSN: 0270-9139 (ISSN-L)
1527-3350
DOI: 10.1002/hep.28251
PMC: PMC4688087
OpenAlex: W2163005196
Cited by: 2,012
References: 40
Citations by year: 2026: 165 · 2025: 255 · 2024: 311 · 2023: 309 · 2022: 342 · 2021: 255 · 2020: 165 · 2019: 92 · 2018: 52 · 2017: 30 · 2016: 26 · 2015: 2
FWCI: 29.04
Type: journal article
Language: en
Update notices: correction (2025-08-01)
Open access: bronze
doi.org
Licence: doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
onlinelibrary.wiley.com/termsAndConditions (vor)
Locations: Hepatology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: University of Pittsburgh
National Natural Science Foundation of China (201508020258, R01GM115366, 201400000003, R01CA160417, 81502445, 31171229, U1132005)
National Institutes of Health (R01GM115366 to D.T.)
National Cancer Institute (R01CA160417)
National Institute of General Medical Sciences (R01GM115366)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
Keywords: ferroptosis, Nrf2, p62, Keap1, hepatocellular carcinoma, erastin, sorafenib, buthionine sulfoximine, quinone oxidoreductase 1, heme oxygenase-1, FTH1, MAFG, ferroptosis-targeted therapy, iron-dependent lipid peroxidation
MeSH terms: Kelch-Like ECH-Associated Protein 1, Animals, Carcinoma, Hepatocellular, Humans, Iron, Liver Neoplasms, Mice, Inbred C57BL, Tumor Cells, Cultured, Signal Transduction, RNA-Binding Proteins, Cell Death, Intracellular Signaling Peptides and Proteins, NF-E2-Related Factor 2, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Activation of the p62–Keap1–NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks